1-3 of 3
Jennifer C. Samp, MS, PharmD
Close
Sort by
Journal Articles

Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno- and Novel Agent-Based Therapy: A Multicenter Study

Anthony R Mato, MD, Maryam Sarraf Yazdy, MD, Brian T. Hill, MD PhD, Mazyar Shadman, Hande Tuncer, MD, Allison M. Winter, MD, Kaitlin Kennard, RN, BSN, John N. Allan, MD, Chaitra S. Ujjani, MD, Danielle M. Brander, MD, Chadi Nabhan, MD, Paul Barr, MD, Jennifer R. Brown, MD PhD, Christopher P. Fox, MD PhD, Joanna Rhodes, MD, Anna Schuh, MD PhD, Toby A. Eyre, MD, Nicole Lamanna, MD, Nitin Jain, MD, William G. Wierda, MD PhD, Alan P Skarbnik, MD, Lindsey E. Roeker, MD, Rajat Bannerji, MD PhD, Andrew M. Evens, MD, Frederick Lansigan, MD, Jennifer C. Samp, MS, PharmD, Jacqueline Nielsen, PhD, James M. Pauff, Thomas J. Kipps, MD PhD, Stephen J. Schuster, MD, George A Follows, MD PhD, Bruce Cheson, MD, Barbara Eichhorst
Journal: Blood
Blood (2018) 132 (Supplement 1): 4759.
https://doi.org/10.1182/blood-2018-99-119015
Published: 2018
Journal Articles

Clinical Benefits of Achieving Deep Remission to Second-Line Therapy in Patients with Relapse/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) - a Real-World Study

William G Wierda, MD PhD, Genevieve Gauthier, MSc, Brian Meissner, PharmD, PhD, Annie Guerin, MS, Jennifer C. Samp, MS, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2130.
https://doi.org/10.1182/blood.V130.Suppl_1.2130.2130
Published: 2017
Journal Articles

Drivers of Treatment Patterns in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with B-Cell Receptor Inhibitors (BCRis) — a Medical Chart Review Study

Anthony R. Mato, MD, Jennifer C. Samp, MS, PharmD, Genevieve Gauthier, MSc, Emi Terasawa, PhD, Danielle M. Brander, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4681.
https://doi.org/10.1182/blood.V130.Suppl_1.4681.4681
Published: 2017